Persistent TNF-α exposure impairs store operated calcium influx in CD4+ T lymphocytes  by Church, Leigh D. et al.
FEBS 29309 FEBS Letters 579 (2005) 1539–1544Persistent TNF-a exposure impairs store operated calcium inﬂux
in CD4+ T lymphocytes
Leigh D. Church*, John E. Goodall, David A. Rider, Paul A. Bacon, Stephen P. Young
Division of Immunity and Infection, Department of Rheumatology, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
Received 2 November 2004; revised 14 January 2005; accepted 17 January 2005
Available online 4 February 2005
Edited by Frances ShannonAbstract Persistent tumour necrosis factor alpha (TNF-a)
exposure uncouples proximal T-cell receptor (TCR)-signalling
events. Here, we demonstrate that chronic TNF-a exposure also
attenuates signalling distal to the TCR, by speciﬁcally inhibiting
Ca2+ inﬂux evoked by thapsigargin in CD4+ T-cells. Mitogen-
induced Ca2+ responses were impaired in a dose dependent
manner, and TCR-induced Ca2+ responses were also signiﬁ-
cantly reduced. The impairment of Ca2+ inﬂux strongly corre-
lated with poor function as proliferative responses to both
mitogen and anti-CD3/CD28 stimulation were suppressed. Our
ﬁndings show that persistent TNF-a exposure of T-cells speciﬁ-
cally inhibits store operated Ca2+ inﬂux. This may aﬀect gene
activation and contribute to the poor T-cell function in chronic
inﬂammatory disease.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Persistent or repeated exposure of T-cells to inﬂammatory
mediators such as tumour necrosis factor alpha (TNF-a) has
been linked with T-cell hyporesponsiveness in chronic inﬂam-
matory diseases, such as rheumatoid arthritis (RA) [1–6].
The advent of TNF-a blocking therapies has been associated
not only with signiﬁcant clinical improvements in RA but also
the restoration of RA T-cell function in vivo and in vitro [7,8].
These studies identiﬁed TNF-a as a key player in the modula-
tion of T-cell function, having both proinﬂammatory and
immunosuppressive eﬀects depending upon the dose and dura-
tion of exposure.
Persistent TNF-a exposure uncouples early T-cell receptor
(TCR)-signalling events leading to decreased proliferation
and cytokine production [1]. Cope et al. [5] and Isomaki et
al. [6] reported that the down regulation of CD3 f chain
expression by repression of gene activation was the principle
cause of the impaired signal transduction. Consequently,
TNF-a treated T-cells have disrupted TCR signalling charac-
terised by reduced ZAP-70 phosphorylation and impaired
Ca2+ signalling. However, it has recently been found that
reconstitution of CD3 f chain failed to restore the responses*Corresponding author. Fax: +44 121 414 6794.
E-mail address: l.d.church@bham.ac.uk (L.D. Church).
0014-5793/$30.00  2005 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2005.01.051of T-cells rendered hyporesponsive by TNF-a [9]. This suggests
that pathways distal to TCR signalling are also targeted, in
addition to the uncoupling of proximal TCR signalling events.
One of the most important of these is the elevation in intracel-
lular Ca2+ ([Ca2+]i), which is necessary for the regulation of
several lymphocyte genes [10], and is known to be aﬀected in
chronic inﬂammation [11–13].
To determine whether persistent TNF-a exposure speciﬁ-
cally impairs human T-cell Ca2+ signalling, we examined the
eﬀects of chronic TNF-a exposure on Ca2+ mobilisation in
T-cells, and correlated the eﬀects with their proliferative re-
sponses. We show that store operated Ca2+ (SOC) inﬂux is spe-
ciﬁcally depressed following chronic TNF-a exposure. This
inhibition directly correlated with impaired function and so
this pathway may contribute to the hyporesponsiveness of
T-cells in chronic inﬂammatory diseases, such as RA.2. Materials and methods
2.1. Isolation of CD4+ CD45RA+ T-cells from peripheral blood
Peripheral blood obtained from healthy donors was diluted 1:1 with
RPMI 1640 medium (Gibco, UK) and layered onto Ficoll-paque
(Pharmacia, Sweden). Samples were centrifuged at 300 · g for 30 min
and the layer of mononuclear cells was collected and washed in RPMI
1640 before removal of adherent cells by a 1-h incubation at 37 C in a
petri dish.
Non-adherent cells were collected and incubated with a cocktail of
monoclonal antibodies containing anti-CD8 (Royal Free Hospital,
London, UK); anti-CD14 (Immunotech, France); anti-CD16 (Immu-
notech, France); anti-CD19 (Royal Free Hospital, London, UK);
CD45RO (P. Beverley, UCH); anti-HLA DR (Birmingham, UK);
and glycophorin (Pharmingen, USA) to label unwanted cells. Labelled
cells were removed with anti-mouse IgG magnetic beads (Dynal, UK)
using a 3-stage depletion of 30 min each. The resulting CD4+
CD45RA+ T-cell population (of greater than 90% purity) was split
for the in vitro culture and for analysis of cell purity by ﬂow cytometry.2.2. T-cell culture
All T-cells were cultured in RPMI 1640 supplemented with 10% heat
inactivated normal human serum, 50% Fibroblast conditioned media,
2 mM L-glutamine, 25 mM HEPES buﬀer, 100 U/ml penicillin, and
100 lg/ml streptomycin at a cell density of 1 · 106 T-cells/ml. CD4+
CD45RA+ T-cells were activated to upregulate surface TNF receptor
expression with 0.05 lg/ml anti-CD3 monoclonal antibody (OKT3)
and co-cultured with c-irradiated Epstein Barr virus transformed B-
cells (10 T-cell:1 B-cell) as feeder cells. Twenty-four hours post-stimu-
lation the ﬁrst addition of TNF-a was added and this was then re-
peated daily for seven days. T-cells were exposed to a dose range of
TNF-a between 0.1 and 10 ng/ml. Following the seven day culture,
T-cells were harvested and split for [Ca2+]i assessment, measurement
of proliferation, phenotype analysis by ﬂow cytometry and determina-
tion of cell viability.blished by Elsevier B.V. All rights reserved.
Fig. 1. (A) Cartoon of the in vitro chronic TNF-a exposure culture
model. Chronic TNF-a exposure of T-cells impairs magnitude of
2+ 2+
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T-cells were resuspended at 2 · 106 cells/ml in RPMI 1640 supple-
mented as before and loaded with Indo 1-AM ester (Molecular Probes,
USA) as previously described [12]. Brieﬂy, T-cells loaded with Indo 1-
AM were resuspended in Ca2+ containing Hanks buﬀered saline solu-
tion (HBSS) at 1.0 · 106 cells/1.5 ml. Cuvettes containing 1.5 ml of the
cell suspension were transferred into a Perkin–Elmer LS50B spectroﬂu-
orometer (Perkin–Elmer, USA) and stimulated with a submaximal
dose of either phytohaemagglutinin protein (PHA-P, 6.7 lg/ml; Difco,
USA) or cross-linked anti-CD3 mAb (0.5 lg/ml). The trace was ob-
served for a period of 10 min, and the baseline, peak and plateau
[Ca2+]i levels were recorded, enabling the peak rise (the peak [Ca
2+]i
minus the baseline [Ca2+]i) and the plateau rise (plateau [Ca
2+]i minus
the baseline [Ca2+]i) to be calculated.
To assess the relative contribution of the release of Ca2+ from intra-
cellular stores and the Ca2+ entry across the plasma membrane (PM) to
the overall rise in [Ca2+]i investigations were performed in Ca
2+ free
HBSS. EGTA (0.4 mM), a Ca2+ chelating agent was added just prior
to [Ca2+]i measurement to ensure that the extracellular Ca
2+ concentra-
tion ([Ca2+]o) was reduced to less than 100 nM. To investigate the con-
tribution of Ca2+ transport across the plasma membrane
independently of TCR stimulated signalling events the endoplasmic
Ca2+ ATPase inhibitor thapsigargin (Tg) (500 nM, Sigma) was used.
Tg bypasses TCR signalling events by inhibiting the reuptake of
Ca2+ into the ER causing the leakage of Ca2+ from ER stores. In
accordance with the capacitative Ca2+ entry theory, the depletion of
the ER store will trigger the opening of SOC channels in the plasma
membrane. The re-addition of Ca2+ to the cell suspension following
stimulation with Tg in Ca2+ free HBSS to replenish the [Ca2+]o to a le-
vel of 1.4 mM causes a rapid rise in [Ca2+]i signal which reﬂects the
contribution of the SOC channels.
Ca2+ inﬂux through SOC channels was also conﬁrmed by manga-
nese (Mn2+) quench analysis. The cells were loaded with Indo 1-AM
as described and transferred to Ca2+ free HBSS just prior to [Ca2+]i
measurement. 20 nM MnCl2 was added to the cuvette before stimulat-
ing the cells with 6.7 lg/ml PHA-P and measuring the quench in the
ﬂuorescent intensity of Indo-1 to determine the rate and magnitude
of Ca2+ inﬂux.
2.4. Measurement of proliferation
Proliferation of control and TNF-a treated T-cells was assessed by a
72 h proliferation assay. Proliferation was measured by stimulation of
T-cells with either PHA-P or by cross-linking anti-CD3 mAbs. For
stimulation with anti-CD3, a 96 well ﬂat bottom plate was coated with
goat anti-mouse IgG antibody (0.5 lg/ml) at 4 C for 24 h prior to the
assay. Excess antibody was washed away with three washes in PBS.
Anti-CD3 mAb was bound to the goat anti-mouse coated plate by
incubating with 0.01 lg/ml OKT3 for 1 h. Following the incubation,
the wells were rinsed three times with PBS. 50 · 103 T-cells were added
to each well. An anti-CD28 mAb was added soluble to each well at a
concentration of 0.2 lg/ml. PHA-P stimulated proliferation was per-
formed with 50 · 103 T-cells stimulated with 6.7 lg/ml PHA-P. The
proliferation assays were performed in triplicate. Eighteen hours prior
to harvesting the cells were pulsed with 3H thymidine. At 72 h, the cells
were harvested onto ﬁlter paper and 3H thymidine incorporation deter-
mined by scintillation counting.
2.5. Statistical analysis
For statistical analysis, the means and SEMs were calculated.
In most cases, diﬀerences between groups were tested for statistical
signiﬁcance using a paired t test and P < 0.05 were considered to be
signiﬁcant.mitogen-induced Ca responses. (B) [Ca ]i responses were examined
in untreated control T-cells and T-cells exposed to 0.1 ng/ml TNF-a
under chronic conditions after stimulation in a spectroﬂuorometer
with 6.7 lg/ml of phytohemagglutinin protein (PHA-P). The baseline,
peak and plateau [Ca2+]i signals were recorded and comparison of the
magnitude of the peak rise in [Ca2+]i (peak [Ca
2+]i signal minus
baseline [Ca2+]i signal) were made. Seven investigations were com-
pleted studying the eﬀect of chronic TNF-a exposure on the magnitude
of the peak rise in [Ca2+]i in T-cells to restimulation. (C) The eﬀect of
chronic TNF-a exposure was examined with three doses of TNF-a
(0.1–10 ng/ml). The diﬀerence in magnitude between control and TNF-
a treated T-cells under chronic conditions were signiﬁcant for all TNF-
a concentrations (* P 6 0.05 and **P 6 0.01).3. Results
3.1. Chronic TNF exposure inhibits PHA-P induced [Ca2+]i
signals in CD4+ T-cells
To investigate whether the persistent exposure of RA T-cells
to TNF-a underlies the impaired Ca2+ signalling and subse-
quently suppress their function, we developed an in vitro
model utilising peripheral blood CD4+ CD45RA+ T-cellsisolated from healthy individuals. This T-cell subset was se-
lected ﬁrstly to ensure that we were investigating the eﬀects
of TNF-a on a homogeneous population and secondly to en-
able the kinetics of TNF-a receptor expression to be studied
throughout the culture period. As naive T-cells do not express
TNF-a receptors, the isolated T-cells were stimulated initially
with soluble anti-CD3 antibody (0.05 lg/ml) and gamma-irra-
diated EBV transformed B-cells to upregulate their TNFR1
and TNFR2 expression. The stimulated T-cells were cultured
for seven days and TNF-a added every 24 h. Following this
period, [Ca2+]i signalling in TNF-a treated and untreated T-
cells was examined and compared (Fig. 1A). TNFR1 and
TNFR2 were both upregulated following stimulation and
expression was comparable between TNF-a treated and un-
treated cells throughout the culture period (data not shown).
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nitude of the peak rise in [Ca2+]i to stimulation with 5.6 lg/ml
of PHA-P implying that either signalling pathways upstream
of Ca2+ mobilisation or Ca2+ signalling itself were impaired
by prolonged TNF-a exposure (Fig. 1B). The basal [Ca2+]i lev-
els were comparable between TNF-a treated and untreated T-
cells. The peak rise in Ca2+ was inhibited by more than 25% in
TNF-a treated cells and this was seen in the subsequent pla-
teau following PHA-P stimulation as well. The inhibition of
Ca2+ responses by chronic TNF-a exposure was statistically
signiﬁcant at all doses of TNF-a (Fig. 1C).
3.2. Chronic TNF exposure inhibits anti-CD3 stimulated
[Ca2+]i signals in CD4+ T-cells
Analysis of TCR-induced Ca2+ signalling through the cross-
linking of CD3 molecules revealed a marked depression in the
magnitude of [Ca2+]i responses following chronic TNF-a
(0.1 ng/ml) exposure (Fig. 2A). As before there were no
changes in intracellular baseline Ca2+ levels indicative of nor-
mal intracellular Ca2+ homeostasis. The peak responses were
impaired following chronic TNF-a exposure, which is reﬂected
in the signiﬁcant suppression of the peak rise by nearly 30%
(P 6 0.05) (Fig. 2B).Fig. 2. (A) Chronic TNF-a exposure of T-cells impairs the magnitude
of anti-CD3 induced Ca2+ responses. [Ca2+]i responses in untreated
control T-cells and T-cells chronically exposed to 0.1 ng/ml TNF-a
were measured after stimulation by cross-linking anti-CD3 mAb
(0.05 lg/ml) with a rabbit anti-mouse antibody (2.5 lg/ml). The
baseline, peak and plateau [Ca2+]i signals were recorded. (B) The
magnitude of the peak rise in [Ca2+]i in T-cells chronically exposed to
0.1 ng/ml TNF-a was signiﬁcantly reduced compared with its paired
control (n = 4, P 6 0.05).3.3. The inhibition of Ca2+ signalling correlates with impaired
T-cell proliferation
A rise in [Ca2+]i is the culmination of several signalling
events triggered following TCR ligation. The amplitude, dura-
tion and pattern of the elevation in [Ca2+]i has been reported to
be essential in the regulation of transcription factors activation
and proliferation. To investigate whether the suppression of
[Ca2+]i signalling induced by prolonged TNF-a exposure im-
paired T-cell function, we assessed T-cell proliferative re-
sponses when re-challenged following chronic TNF-a
exposure.
The inhibition of [Ca2+]i responses by TNF-a was also re-
ﬂected in their poor proliferation (Fig. 3A). Proliferative re-
sponses to PHA-P and to stimulation with plate bound anti-
CD3 antibody (0.01 lg/ml) and soluble anti-CD28 (0.05 lg/
ml) antibody were signiﬁcantly impaired compared with un-
treated controls (P 6 0.05). The inhibition of proliferation di-
rectly correlated (r2 = 0.9024, P 6 0.05) with impaired Ca2+
responses (Fig. 3B). Viability of the cells as determined by pro-
pidium iodide uptake was comparable between TNF-a treated
and untreated cells (data not shown). This data suggests thatFig. 3. (A) Chronic TNF-a exposure inhibits T-cell proliferation. T-
cell proliferative responses of TNF-a treated (0.1 ng/ml) and untreated
T-cells under chronic conditions to PHA-P and anti-CD3/CD28
restimulation were assessed in triplicate. The graph represents the
mean proliferation over 72 h and is representative of 3 pairs of tests in
each case. There was a signiﬁcant diﬀerence in the proliferative
responses between control and TNF-a treated T-cells (P 6 0.05) when
restimulated with either PHA-P or anti-CD3/CD28. (B) Analysis of the
magnitude of PHA-P induced Ca2+ responses with the proliferation
following chronic TNF-a exposure revealed a strong correlation
(r2 = 0.9024, P 6 0.05).
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sure has important functional consequences.
3.4. Chronic TNF exposure impairs Ca2+ inﬂux across the
plasma membrane through SOC channels
As our initial observations showed that [Ca2+]i signalling
was impaired, we then examined the diﬀerent components in-
volved in the mobilisation of Ca2+. Ca2+ released from the
internal stores after TCR ligation can be assessed indepen-
dently of Ca2+ transport across the plasma membrane by stim-
ulating the cells with thapsigargin (Tg) in the absence of
extracellular Ca2+. The inﬂux of Ca2+ through SOC channels
in the plasma membrane can then be speciﬁcally examined
independently of the TCR by the re-addition of Ca2+ to the
medium.
The release of Ca2+ from intracellular stores by Tg stimula-
tion was comparable between TNF-a treated and untreated T-
cells (Fig. 4A and B), but a marked inhibition in the activity of
the plasma membrane Ca2+ channels was observed as the mag-
nitude of inﬂux was signiﬁcantly reduced by more than 30% in
the TNF-a treated T-cells (P 6 0.001) (Fig. 4A and B). The
addition of EGTA to TNF-a treated and untreated cells in
Ca2+ containing HBSS after mitogen stimulation revealed thatFig. 4. (A) Chronic TNF-a exposure of T-cells impairs SOC inﬂux. Tg
was used to induce a release of Ca2+ from intracellular stores bypassing
the TCR. Application of Tg under Ca2+ free conditions enabled the
measurement of plasma membrane Ca2+ channel activity independent
of TCR signals in control and chronic TNF-a treated T-cells. No
diﬀerence in the magnitude of Tg-induced Ca2+ release was observed
between control and TNF-a treated T-cells. The re-addition of Ca2+ to
the cell suspension revealed that the plasma membrane SOC channels
however was impaired in chronic TNF-a treated. (B) The magnitude of
Tg-induced Ca2+ releases and subsequent Ca2+ inﬂux for control and
chronic TNF-a treated T-cells from three separate experiments are
shown (P 6 0.01).Ca2+ eﬄux was unaﬀected (data not shown). The inhibition in
the Ca2+ inﬂux by persistent TNF-a exposure was also con-
ﬁrmed by performing Mn2+ quench analysis (Fig. 5). Follow-
ing stimulation with PHA-P the rate and magnitude of the
quench in ﬂuorescent intensity of the Ca2+ dye Indo 1 by the
inﬂux of Mn2+ was greatly reduced in the TNF-a treated T-
cells compared with untreated control cells. This observation
identiﬁes the SOC inﬂux as the target for inhibition by chronic
TNF-a exposure.4. Discussion
In the present work, the eﬀect of persistent TNF-a exposure
on distal TCR signalling pathways has been examined. We
showed that Ca2+ signalling induced through the TCR by
mitogen or anti-CD3 cross-linking was perturbed which would
appear to support previous ﬁndings of altered proximal TCR
signalling after persistent TNF-a exposure [4–6]. The reduced
Ca2+ response was reﬂected in the depressed proliferation.
While attenuation of proximal TCR signalling events have pre-
viously been reported to alter Ca2+ responses, a direct eﬀect of
persistent TNF-a exposure on Ca2+ signalling has yet to be
examined. Here, we have shown that SOC inﬂux is speciﬁcally
perturbed and this occurs independently of proximal TCR sig-
nalling events.
Engagement of the TCR initiates a cascade of signalling
events culminating in a rise in [Ca2+]i and the subsequent acti-
vation of transcription factors [10]. The rise in [Ca2+]i is a com-
bination of internal store release and inﬂux across the plasma
membrane and must be above a sustained threshold in order to
facilitate T-cell activation [14,15]. Previously, Cope et al. [5]
and Isomaki et al. [6] reported that the down regulation of
CD3 f chain expression by repression of gene activation was
the principle cause of the impaired signal transduction follow-
ing persistent TNF-a exposure. A consequence of this is that
TNF-a treated T-cells have disrupted TCR signalling charac-
terised by reduced ZAP-70 phosphorylation and impaired
Ca2+ signalling. However, recent ﬁndings that reconstitutionFig. 5. Investigation of Ca2+ inﬂux by Mn2+ quench. Inhibition of
Ca2+ inﬂux by chronic TNF-a exposure was conﬁrmed by Mn2+
quench analysis. The solid (–––) line represents control untreated T
lymphocytes that were not stimulated with the mitogen PHA-P. The
bold solid ( ) line represents control, PHA-P stimulated T
lymphocytes and the dotted (ÆÆÆÆ) line represents T lymphocytes exposed
to 10 ng/ml TNF-a for seven days. This graph is representative of two
independent experiments. Both the rate and magnitude of the quench
is impaired in the TNF-a treated T lymphocytes.
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dered hyporesponsive by TNF-a would support the proposal
that TNF-a has additional eﬀects on pathways distal to TCR
proximal events [9].
Our data reveal that whilst the size of the intracellular Ca2+
store release remains unchanged following long-term exposure
to TNF-a, the activity of SOC channels in the plasma mem-
brane are altered. The use of thapsigargin to induce the rise
in [Ca2+]i required for SOC inﬂux independent of TCR activa-
tion, identiﬁed the inﬂux of Ca2+ across the plasma membrane
to be signiﬁcantly impaired.
The precise pathway by which chronic TNF-a exposure im-
pairs T-cell [Ca2+]i inﬂux is still unknown. The regulation of
SOC activity is also complex and not yet clearly deﬁned. Cur-
rent dogma supports the capacitative entry theory in which a
decrease in store Ca2+ concentration is proposed to activate
SOCs in the plasma membrane by an as yet unresolved
mechanism [16]. In T-cells there is strong evidence that the
TCR-activated Ca2+ channel is identical to the Ca2+-release-
activated Ca2+ (CRAC) channel [17]. For example, both store
depletion and TCR ligation activate a channel with identical
properties and in a human primary immunodeﬁciency caused
by an absence of the CRAC channel, there is no TCR-acti-
vated Ca2+ inﬂux [18]. CRAC channels, however, may not
be the only SOC channels involved. There are suggestions that
other plasma membrane channels such as the ICRANC channel
or the non-voltage gated L-type channels play minor roles in
lymphocyte SOC inﬂux, but the evidence to support this is less
clear [17,19]. The Ca2+ inﬂux through SOC channels is ulti-
mately driven by membrane potential and although T-cells
are non-excitable cells they do express both voltage gated K+
channels (Kv) and Ca
2+-activated K+ channels (KCa) whose
function is to maintain the resting membrane potential [20].
Following store depletion, KCa are activated and hyperpolar-
ize the membrane. This makes the membrane more negative
and enhances the Ca2+ inﬂux by increasing the inward driving
force for Ca2+ entry. Our data is consistent with a mechanism
of inhibition by persistent TNF-a exposure that acts on SOC
channels directly such as the CRAC channel or indirectly
through alteration of K+ channels.
Recently, it has been recognised that Ca2+ entry through
CRAC channels can be regulated by the activation of acidic
sphingomyelinase (ASM) following ligation Fas (CD95), a
member of the TNF receptor family, on T-cells [21]. Activation
of ASM results in the release of the sphingolipid second mes-
senger ceramide [22]. Ceramide has been proposed to inhibit
SOC channels by impairing the K+ channel Kv1.3 [23].
Kv1.3 like CRAC channels are localised in small lipid rafts de-
void of ceramide. The accumulation of ceramide converts the
small rafts into large ceramide-enriched rafts and the tight
packing of the lipids alters the physical properties of the rafts
impairing Kv1.3 activity. We have found that under acute con-
ditions, TNF-a exposure (3 h) can regulate TCR responses by
reversibly modulating Ca2+ inﬂux through a TNFR1 depen-
dent pathway activating ASM [24]. This observation supports
the notion that inhibition of Ca2+ inﬂux by TNF-a may actu-
ally precede the aberrations in proximal TCR signalling fol-
lowing persistent TNF exposure. It is plausible that under
chronic conditions TNF-a exposure also activates ASM and
leads to a persistent inhibition of Ca2+ inﬂux, as observed here.
Evidence for this is currently being investigated within our lab.We have previously reported perturbations in both the mag-
nitude and pattern of Ca2+ responses in synovial T-cells iso-
lated from patients with RA [11–13]. Preliminary studies in
our lab also suggest that the T-cell Ca2+ inﬂux to be speciﬁcally
impaired in these patients. Thus, the identiﬁcation of the
mechanism for the inhibition of SOC inﬂux is crucial to the
understanding of the molecular basis underlying the hypore-
sponsiveness of T-cells and the pathogenesis of chronic inﬂam-
matory diseases such as RA. Deﬁning the mechanism will not
only aid in identifying the relationship between proximal and
distal signalling abnormalities following chronic TNF-a expo-
sure but will also highlight potential targets for therapeutic
beneﬁt.
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